Issue 01 · October 2026
Crestpath Brief
A clearer view of peptide research and pharmacy rules.
For clinic owners and curious readers. Source-linked reporting, with a clear line between research, regulation and a sales pitch.
Read the lead article →
In this issue
Research literacy · 4 minute read
Peptide research: what a study can actually tell you
Before a headline becomes a decision, check who was studied, what was tested and what remains unknown.
Read article →Pharmacy policy · 3 minute read
Compounded does not mean FDA-approved
FDA's April 2026 reminder separates patient-specific compounding from broad claims about availability.
Read article →The brief, by email
Keep up without the noise.
Research context and pharmacy-policy updates, in plain language. No dosing guidance or product offers.
About the brief
Crestpath Brief is educational editorial content. Crestpath Health is a separate price comparison service for medical practices and research businesses. We do not sell healthcare products, prescribe or dispense medicines.
Explore Crestpath's business comparison serviceEducational editorial content. Crestpath provides business price comparisons, not healthcare products or medical advice.